<DOC>
	<DOCNO>NCT02409004</DOCNO>
	<brief_summary>This single centre , Phase I , open-label , one cohort , one dose level , fixed-sequence , drug interaction study healthy volunteer . The objective study determine effect rifampin pharmacokinetics ataluren fast condition .</brief_summary>
	<brief_title>Effects Rifampin Pharmacokinetics Ataluren</brief_title>
	<detailed_description />
	<mesh_term>Rifampin</mesh_term>
	<criteria>Healthy Male Nonsmoker ≥18 ≤55 year age Clinically significant laboratory , electrocardiogram , vital sign abnormality screen Positive urine drug screen screen History significant drug alcohol abuse Recent use medication topical product without significant systemic absorption Recent donation plasma blood loss blood</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Drug-drug interaction</keyword>
</DOC>